ARCHIVES

ACS Defends Dialogue, Calls Story “Misleading”.

This article is from The Cancer Letter archive.

Vol. 26 No. 38 | October 20, 2000

Download PDF Visit The Full Archive

Related Articles

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

April 15, 2011

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

CMS Withholds Coverage of CT Colonography

May 15, 2009

In Brief: Taxol Development Is NCI ‘Emergency Priority’, Dodd To Focus ACS Effort On Breast Screening

December 7, 1990

Report Says Many Cancers Could Be Prevented

February 27, 2009

Sullivan Confirmation Hearing Set For Feb. 1

January 27, 1989